For research and educational purposes only. Not medical advice.

TB-500 Reference

Educational, not medical advice reference for TB-500: Recovery; regulatory status, evidence posture, source review, and schedule notes. Also known as Thymosi…

Reference summary

Evidence is mostly extrapolated from thymosin beta-4 animal literature on tissue repair and myocardial injury. Human TB-500-specific clinical evidence is not established.

Categories
Recovery
Aliases
Thymosin beta-4 fragment, TB4 fragment
Evidence posture
preclinical — Commercial claims lean heavily on thymosin beta-4 extrapolation, not direct human TB-500 trials.
Regulatory status
No FDA-approved TB-500 drug label. Published literature more often studies full-length thymosin beta-4 than commercial TB-500 vials, so exact product identity matters.
Content review status
research reference

Selected public sources